2014
DOI: 10.1016/j.ygcen.2014.03.042
|View full text |Cite
|
Sign up to set email alerts
|

Endocrinology: Advances through omics and related technologies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 171 publications
0
9
0
Order By: Relevance
“…We linked these changes with altered biological endpoints caused by exposure to EE2. Transcriptomics approaches have been used to identify specific modes of action associated with biological responses to chemical exposures (Garcia-Reyero et al 2014; Levi et al 2009; Miller et al 2012). Identifying genes and pathways that may result in specific phenotypic alterations in organisms provides valuable insight into the mechanism of action of EE2.…”
Section: Introductionmentioning
confidence: 99%
“…We linked these changes with altered biological endpoints caused by exposure to EE2. Transcriptomics approaches have been used to identify specific modes of action associated with biological responses to chemical exposures (Garcia-Reyero et al 2014; Levi et al 2009; Miller et al 2012). Identifying genes and pathways that may result in specific phenotypic alterations in organisms provides valuable insight into the mechanism of action of EE2.…”
Section: Introductionmentioning
confidence: 99%
“…While this trend has gained traction in the biomedical sciences community, it has recently surged in the environmental monitoring and comparative endocrinology arena (Garcia-Reyero et al, 2014; Jungnickel et al, 2014; Scanlan et al, 2015; Schneider and Orchard, 2011). In this study, we created a new ‘eicosanomic’ strategy for the quantitation of the eicosanoid milieu in non-traditional species, models, and/or matrices.…”
Section: Discussionmentioning
confidence: 99%
“…Protein-protein interaction [31] Hypertension [32] Renal diseases [33,34] Tuberculosis [35] Cardiovascular homeostasis [36] Endocrine processes [37] Atherosclerosis [38] Chronic pulmonary obstruction [39] Cancer [40][41][42][43][44] Virus infection [45] Arthritis [46] Doping [47] Process/Disease Protein-protein interaction [31] Hypertension [32] Renal diseases [33,34] Tuberculosis [35] Cardiovascular homeostasis [36] Endocrine processes [37] Atherosclerosis [38] Chronic pulmonary obstruction [39] Cancer [40][41][42][43][44] Virus infection [45] Arthritis [46] Doping [47] Citation: Plaza Table 1). This technical-analytical boom, among others, led to the development of the called "human genome project" for instance (Https://www.genome.gov/10001772/allabout-the--human-genome-project-hgp/).…”
Section: Process/diseasementioning
confidence: 99%